An article written by Fenwick’s Robert Counihan, Eric Majchrzak and Erica Sutter was featured on Bloomberg Law exploring the remedies that patentees could seek against a pharmaceutical company looking to launch a new drug product, specifically the launch of new “innovator” products as opposed to generics.

Read the full article here: Professional Perspective: Patent Holder Remedies & Drug Product Launches


Don’t have an account yet?